How can hepatitis C be prevented in the long term?

Area of Science:

• Public Health
• Infectious Diseases
• Sociology

Background:

• Hepatitis C (HCV) remains prevalent among injecting drug users (IDUs) despite harm reduction programs.
• Knowledge gaps exist in understanding HCV prevention strategies for IDUs.
• Current research often focuses on risk, neglecting protective factors.

Purpose of the Study:

• To identify strategies, behaviors, and environmental factors that enable some IDUs to remain uninfected with HCV.
• To shift research focus from risk to protective elements in HCV prevention.
• To inform the development of novel HCV prevention programs for IDUs.

Main Methods:

• A qualitative research approach focusing on "staying safe" behaviors.
• Comparative studies across four international locations: New York City, Valencia, Sydney, and London.
• Collaboration with IDUs to understand their expert-driven prevention methods.

Main Results:

• Preliminary findings suggest unique individual and environmental factors contribute to HCV non-infection in IDUs.
• The research highlights the importance of social and cultural contexts in shaping prevention strategies.
• Identified a need to understand the "vagaries of human strategic discovery" by drug users.

Conclusions:

• Understanding how some IDUs avoid HCV infection is crucial for effective prevention.
• A new generation of HCV prevention programs can be developed by learning from "expert" uninfected IDUs.
• The "Staying Safe" studies provide a conceptual foundation for long-term HCV prevention in IDU populations.